Team:Tec-Monterrey/safetypage

From 2011.igem.org

(Difference between revisions)
 
(47 intermediate revisions not shown)
Line 1: Line 1:
<html xmlns="http://www.w3.org/1999/xhtml"><head>
<html xmlns="http://www.w3.org/1999/xhtml"><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
 +
 +
<title>wiki</title>
<title>wiki</title>
<style type="text/css">
<style type="text/css">
<!--
<!--
#top-section {
#top-section {
-
 
+
      height: 100px;
-
  height: 100px;
+
   border: none;
   border: none;
   height:20px
   height:20px
Line 44: Line 45:
     border-left: 0 solid;
     border-left: 0 solid;
     border-right: 0 solid;
     border-right: 0 solid;
-
     width: 100%;
+
}
 +
#content{
 +
     width: 80%;
}
}
Line 57: Line 60:
   .firstHeading {
   .firstHeading {
     display: none;}
     display: none;}
-
 
body {
body {
font: 12px Tahoma, Geneva, sans-serif;
font: 12px Tahoma, Geneva, sans-serif;
-
background-image: url(https://static.igem.org/mediawiki/2011/f/f4/Fondo03.png);
+
background-image: url(https://static.igem.org/mediawiki/2011/4/43/Lefondoleposter.png);
 +
        background-repeat:no-repeat;
 +
      background-size: 100%;
margin: 0;
margin: 0;
padding: 0;
padding: 0;
Line 83: Line 87:
}
}
-
ul.nav li {
+
 
-
border-bottom: 0px solid #04191d;
+
-
+
-
}
+
a:link {
a:link {
Line 101: Line 102:
.container {
.container {
-
width: 90%;
+
width: 100%;
max-width: 1260px;
max-width: 1260px;
min-width: 780px;
min-width: 780px;
Line 111: Line 112:
.sidebar1 {
.sidebar1 {
float: left;
float: left;
-
width: 20%;
+
width: 15%;
-
padding-bottom: 10px;
+
        padding-bottom: 10px;
background-color:#04191d;
background-color:#04191d;
 +
-moz-border-radius: 8px;
 +
-webkit-border-radius: 8px;
}
}
Line 134: Line 137:
border-top:none;  
border-top:none;  
margin-bottom: 15px;
margin-bottom: 15px;
 +
}
}
 +
ul.nav li {
 +
border-bottom: 0px solid #04191d;
 +
 +
}
ul.nav a, ul.nav a:visited {  
ul.nav a, ul.nav a:visited {  
Line 145: Line 153:
}
}
ul.nav a:hover, ul.nav a:active, ul.nav a:focus {  
ul.nav a:hover, ul.nav a:active, ul.nav a:focus {  
-
background: #f6af1b; /*float amarillo*/
+
background: #339dff; /*float amarillo*/
color: #FFF;
color: #FFF;
}
}
-
 
+
.frame {
 +
font:12px arial;
 +
width:700;
 +
height:350;
 +
max-height: 350px;
 +
border:none;
 +
overflow:auto;
 +
border:0px solid black;
 +
padding:5;
 +
}
.fltrt {   
.fltrt {   
float: right;
float: right;
Line 180: Line 197:
}
}
 +
 +
table {
 +
    background: none repeat scroll 0 0 transparent}
Line 191: Line 211:
-moz-border-radius: 3px;
-moz-border-radius: 3px;
-webkit-border-radius: 3px;
-webkit-border-radius: 3px;
-
border-bottom: 0px solid #04191d;
+
border-bottom: 0px solid #04191d;  
}
}
Line 197: Line 217:
/* panel heading on rollover */
/* panel heading on rollover */
.panel h2:hover, .panelcollapsed h2:hover {
.panel h2:hover, .panelcollapsed h2:hover {
-
background-color: #FC3;
+
background-color: #339dff;
color: #FFF;
color: #FFF;
}
}
Line 208: Line 228:
background-position: 280px;
background-position: 280px;
}
}
-
 
-
 
-
 
-
 
-
 
/* panel content - do not set borders or paddings */
/* panel content - do not set borders or paddings */
Line 219: Line 234:
overflow: hidden;
overflow: hidden;
font-size: 14px;
font-size: 14px;
-
margin:0px;
 
-
padding: 0px;
 
}
}
Line 226: Line 239:
.panelcollapsed .panelcontent { display: none; }
.panelcollapsed .panelcontent { display: none; }
 +
-->
 +
</style><!--[if lte IE 7]>
 +
<style>
 +
.content { margin-right: -1px; }
 +
ul.nav a { zoom: 1; } 
 +
</style>
 +
<![endif]-->
 +
<script type="text/javascript">
 +
<!--
 +
i = 0
 +
var speed = 10
-
/* panel heading */
+
function scrollDown() {
-
.panel h3, .panelcollapsed h3
+
i = i + speed
-
{
+
var div = document.getElementById("frame1")
-
color: #e5e5e5;
+
div.scrollTop = i
-
font-weight: normal;
+
if (i > div.scrollHeight - 300) {i = 350}
-
margin:5px 200px;
+
t1=setTimeout("scrollDown()",100)
-
padding: 5px;
+
-
-moz-border-radius: 3px;
+
-
-webkit-border-radius: 3px;
+
}
}
-
 
+
function scrollUp() {
-
 
+
i = i - speed
-
/* panel heading on rollover */
+
var div = document.getElementById("frame1")
-
.panel h3:hover, .panelcollapsed h3:hover {
+
div.scrollTop = i
-
background-color: #f6d41b;
+
if (i < 0) {i = 0}
-
color: #000;
+
t1=setTimeout("scrollUp()",100)
-
+
}
}
-
/* heading of a collapsed panel */
 
-
.panelcollapsed h3
 
-
{
 
-
background-image: url(arrow-dn.gif);
 
-
background-repeat: no-repeat;
 
-
background-position: 280px;
 
-
}
 
-
.gallery {
 
-
margin-right: 100px;
 
-
margin-left: 100px;
 
-
overflow: visible;
 
-
}
 
-
.thumbs {
 
-
height: 112px;
 
-
width: 550px;
 
-
display: table;
 
-
text-align: center;
 
-
background-attachment: scroll;
 
-
background-color: #000;
 
-
background-repeat: no-repeat;
 
-
list-style-type: none;
 
-
overflow: auto;
 
-
}
 
-
 
-
-->
 
-
</style><!--[if lte IE 7]>
 
-
<style>
 
-
.content { margin-right: -1px; }
 
-
ul.nav a { zoom: 1; } 
 
-
</style>
 
-
<![endif]-->
 
-
 
-
<script type="text/javascript">
 
-
<!--
 
Line 295: Line 281:
var PANEL_COLLAPSED_CLASS = "panelcollapsed";
var PANEL_COLLAPSED_CLASS = "panelcollapsed";
var PANEL_HEADING_TAG    = "h2";
var PANEL_HEADING_TAG    = "h2";
-
var PANEL_HEADING_TAG2    = "h3";
 
var PANEL_CONTENT_CLASS  = "panelcontent";
var PANEL_CONTENT_CLASS  = "panelcontent";
var PANEL_COOKIE_NAME    = "panels";
var PANEL_COOKIE_NAME    = "panels";
Line 306: Line 291:
// get all headings
// get all headings
-
var ht2 = document.getElementsByTagName(PANEL_HEADING_TAG);
+
var headingTags = document.getElementsByTagName(PANEL_HEADING_TAG);
-
var ht3 = document.getElementsByTagName(PANEL_HEADING_TAG2);
+
-
+
-
var c1 = 0;
+
-
var c2 = 0;
+
-
var full = ht2.length + ht3.length;
+
-
var headingTags = new Array(full);
+
-
+
-
for (var j = 0; j < full; j++)
+
-
{
+
-
if (c1 < ht2.length) {
+
-
headingTags[j] = ht2[c1];
+
-
c1++;
+
-
}
+
-
if (c1 >= ht2.length) {
+
-
headingTags[j] = ht3[c2];
+
-
c2++;
+
-
}
+
-
}
+
// go through all tags
// go through all tags
Line 395: Line 362:
var direction = (!expanding ? -1 : 1);
var direction = (!expanding ? -1 : 1);
 +
if (direction > 0)
 +
collapseAll();
setTimeout(function(){animateStep(panelContent,1,stepHeight,direction)}, PANEL_ANIMATION_DELAY);
setTimeout(function(){animateStep(panelContent,1,stepHeight,direction)}, PANEL_ANIMATION_DELAY);
}
}
-
 
+
/**
 +
* Change the height of the target
 +
* @param panelContent reference to the panel content to change height
 +
* @param iteration current iteration; animation will be stopped when iteration reaches PANEL_ANIMATION_STEPS
 +
* @param stepHeight height increment to be added/substracted in one step
 +
* @param direction 1 for expanding, -1 for collapsing
 +
*/
function animateStep(panelContent, iteration, stepHeight, direction)
function animateStep(panelContent, iteration, stepHeight, direction)
{
{
Line 509: Line 484:
   
   
<div class="topbar">  
<div class="topbar">  
-
     <div style="background: url(https://static.igem.org/mediawiki/2011/6/60/Topbar_imagebackground.png);
+
     <div style="filter:alpha(opacity=70);opacity:.7;">
-
    background-repeat:no-repeat;
+
-
    background-position:top;">
+
      
      
-
    <p><img name="" src="https://static.igem.org/mediawiki/2011/7/78/Imagtransp.png" width="110" height="32" alt=""><img src="https://static.igem.org/mediawiki/2011/2/20/Logotec.png" alt="ITESM" name="teclogo" width="146" height="52" id="teclogo">  
+
 
 +
<img src="https://static.igem.org/mediawiki/2011/2/20/Logotec.png" alt="ITESM" name="teclogo" width="146" height="52" id="teclogo">  
       <a href="https://2011.igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/2011/7/73/Logoigemsmall.png" alt="iGEM" name="logoigem" width="70" height="61" id="logoigem"></a>
       <a href="https://2011.igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/2011/7/73/Logoigemsmall.png" alt="iGEM" name="logoigem" width="70" height="61" id="logoigem"></a>
     <p>&nbsp;</p>
     <p>&nbsp;</p>
Line 542: Line 516:
     <div class="panelcontent" style="">
     <div class="panelcontent" style="">
     
     
-
 
+
       
 +
                  <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectoverview">overview</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectparts">parts</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectparts">parts</a></p>
-
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectmodeling">modeling</a></p>
+
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectmodeling">genetic frame</a></p>
 +
            <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectresults/methods">methods</a></p>
 +
            <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectresults">results</a></p>
 +
            <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teamha">human approach</a></p>
 +
            <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectprotocols">protocols</a><p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/safetypage">safety</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/safetypage">safety</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectnotebook">notebook</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectnotebook">notebook</a></p>
-
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectresults">results</a></p>
+
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/sampledata">sample data</a></p>
           </div>
           </div>
</div>
</div>
Line 559: Line 538:
    <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teammembers">members</a></p>
    <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teammembers">members</a></p>
-
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teaminstallations">installations</a></p>
+
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teaminstallations">headquarters</a></p>
-
            <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teamha">human approach</a></p>
+
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/microcongreso">micro congress</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/microcongreso">micro congress</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teamfriends">friends</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teamfriends">friends</a></p>
Line 566: Line 544:
  </div>
  </div>
</div>
</div>
-
       </li><li>
+
       </li>
 +
  <li>
       <div class="panelcollapsed">
       <div class="panelcollapsed">
-
 
+
        <h2>EXTRAS</h2>
-
 
+
-
                  <h2>EXTRAS</h2>
+
     <div class="panelcontent">
     <div class="panelcontent">
-
+
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/sitemap">site map</a></p>
-
 
+
-
            <p><a href="https://2011.igem.org/Team:Tec-Monterrey/sitemap">site map</a></p>
+
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/sponsorsplatinum">sponsors platinum</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/sponsorsplatinum">sponsors platinum</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/sponsorsgold">sponsors gold</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/sponsorsgold">sponsors gold</a></p>
Line 580: Line 555:
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/specialthanks">special thanks</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/specialthanks">special thanks</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/followus">follow us!</a></p>
             <p><a href="https://2011.igem.org/Team:Tec-Monterrey/followus">follow us!</a></p>
-
 
+
    </div>
-
                </div>
+
  </div>
-
</div>
+
       </li>
       </li>
     </ul>
     </ul>
Line 589: Line 563:
    
    
<div class="content">
<div class="content">
-
  <!--in sub pages, this divisions should be comments! :D-->
+
<div style="
-
       
+
text-align:center;">
-
  <div class="quicklinks">  
+
<a href="https://2011.igem.org/Team:Tec-Monterrey/safetypage"><img src="https://static.igem.org/mediawiki/2011/3/3d/Safetyqa01.png" > </a>
-
 
+
<a href="https://2011.igem.org/Team:Tec-Monterrey/safetypage/qanda">
-
  <div style="  
+
<img src="https://static.igem.org/mediawiki/2011/d/d6/Biosafty01.png"> </a>
-
  text-align: center;
+
-
      background:url(https://static.igem.org/mediawiki/2011/d/d3/Fondoleer.png);
+
<!--in sub pages, this divisions should be comments! :D-->
-
  background-repeat:no-repeat;
+
        <div style="
-
padding-left: 20px;
+
padding:25px 50px;
-
         background-position:top;
+
         background-color:#04191d;
-
         color:#FFF;
+
         color:#333;
 +
text-align:left;
 +
margin:5px 30px;
   ">
   ">
-
    <p>&nbsp;</p>
+
   
-
    <div class="panelcollapsed">
+
</head>
-
      <h3>Biosafety in the project and regulations in Mexico</h3>
+
-
  <div class="panelcontent" style="text-aling: justify; margin:5px 35px 5px 100px; padding 5px; background-color:#e5e5e5; color:#333; ">
+
-
        <p>&nbsp;</p>
+
-
          <p>&nbsp;</p>
+
-
    <p class="textojustif">Unlike other countries, for example U.S.A., in Mexico the terms &quot;biosafety&quot; and &quot;biosecurity&quot; are not used; instead, the term &quot;biosafety&quot; comprises both of them, with the definition of &quot;biosafety&quot; as &quot;the actions and measures of evaluation, monitoring, control and prevention that must be assumed when carrying out activities with genetically engineered organisms, with the intention to prevent, avoid or reduce any possible risk that those activities could cause to the human health or the environment and biological diversity, including the harmlessness aspects of those organisms destined to their use or consumption.<br />
+
-
      </p>
+
-
    <p class="textojustif"><br />
+
-
      In this project, according to the ADCP (Approved List of Biological Agents), the organism that we are using has a biosecurity level of 2. This information tells us that the host could present some risk, because Escherichia coli is infectious to mammals, including human beings. These bacteria can be acquired by injection, ingestion or autoinoculation.<br />
+
-
      <br />
+
-
      The project involves two constructs with different functions, neither of them codify to any hazardous substance. In the first case, the organism has a higher impact to human health because of the biosecurity level of E. coli where membrane proteins with enzymes will be bound. The reactant that shall be transformed is saccarose with the help of a beta-fructofuranosidase, obtaining fructose and glucose in the process, neither of them being harmful to the environment. For the second case, the initial reactant is cellulose, being transformed to glucose monomers via a cellulase; this could be possibly harmful to the environment in case the bacteria escape the laboratory, due to cellulose being the main component of the cell wall of plants. <br />
+
-
      <br />
+
-
      This could represent a problem and an environmental impact asessment should be done; however, with the appropriate measurements, bacteria should not escape from the area where they are manipulated (inside the laboratory), to not affect the public safety. Nevertheless, there is no evidence in the literature of any previously reported hazard of that enzyme, despite being used in industrial applications and bioremediation.<br />
+
-
      <br />
+
-
      Health problems during investigation are not present if scientists follow suitable laboratory practices and facilities. In order to accomplish this, we talked with the coordinators of the Investigation Laboratory; they told us the minimum safety requirements to work and the disposal of waste, to make sure that the microorganisms we worked with could not be freed to the environment due to an accident or irresponsibility.<br />
+
-
      <br />
+
-
      We found that the Biotechnology School and &quot;Centro de Biotecnología FEMSA&quot; (FEMSA's Biotechnology Center), where we worked, had a Biosafety Committee that reviewed the protocols employed in the laboratory, the substances we employ and the protocol of hazardous waste management, including the use, treatment and disposal of these kind of waste. Subsequently, we asked the Committee for a visit to our laboratory to check that the previously written measures were correctly applied or, if not, to make suggestions to strenghten the protocol's weak points. Moreover, we sought advice from the president of the Biosafety Committee of the Medicine School of Tec de Monterrey, campus Monterrey. This allowed us to have two different points of view about the measurements applied in the laboratory.<br />
+
-
      <br />
+
-
      In our project could be diverse biosecurity problems. In order to go beyond all of these obstacles, first of all, the level of biosafety required to each project must be known. If any of the parts codify for a toxin, or the organism used is highly infectious, stricter measures must be taken. Once the complete information of the project is known, it is important to follow the pertinent rules, laws and regulations.<br />
+
-
      <br />
+
-
      Mexico posess the &quot;Ley de Bioseguridad de Organismos Genéticamente Modificados&quot; (Biosecurity Law for Genetically Modified Organisms), which establish that, in the case of scientific and technologic investigation, the GMO must be used in confinement. Also, it is necessary to fill a registry book for the activities of confined use that are done, to apply the confinement measures whose ejecution must adapt to the most advanced and modern scientific and technologic knowledge of risk management and treatment, final disposal and waste elimination of GMO generated in the execution of diverse activities. Another of the neccesary means, as dictated by the law, is to form an internal biosafety commission, who must to make sure that the principles of good practices of scientific investigation are applied, and the biosafety rules are followed as the commission defines.<br />
+
-
      <br />
+
-
      Regarding the placing, handling, treatment and disposal of hazardous waste, we followed the neccessary means that establishes the &quot;Norma Oficial Mexicana&quot; (Mexican Oficial Regulation) NOM-087-ECOL-SSA1-2002. Based on this regulation, disposable Petri dishes and plastic tubes with biological waste were placed in autoclave resistant bags for biohazardous waste, then placed in the autoclave. The pipette tips were left in containers filled with antibenzil (benzalconium chloride) 1x for an entire day then placed in a red bag for hazardous waste.  The liquid waste were placed also in containers filled with antibenzil 1x. All the waste were then transported to the temporary warehouse for waste of the &quot;Laboratorio de Investigación del Centro de Biotecnología FEMSA&quot;. In order to accomplish this correctly, the coordination gave us the handbook for waste handling of the Investigation Laboratory, and we adapted it to our needs. Also, the coordinators instructed us about how to handle each kind of waste, to not have problems when transporting them to their respective area of the temporary warehouse.<br />
+
-
      <br />
+
-
      It is of great importance to have a good knowledge of the  necessary safety measures for working in the laboratory, because the safety of people working on it, and the success of the project, depend of that. Nevertheless, occasionally it is important that when investigators know the risks and benefits of their work, also they should inform to the rest of the population. Unfortunately, information about genetically engineered organisms not always reaches the people in a correct way. This is because the society's perception towards GMOs is more subjective than objective, being influenced by terms or situations unknown to them.<br />
+
-
      <br />
+
-
      Regarding our biosafety approach, we made a survey related to the topic in order to measure the knowledge of people about biosafety and to know their opinion about genetically engineered food or GMOs used in the fabrication of products of diary consumption. The results can be seen in the biosafety page. A total of 100 people were surveyed. Despite 49% of them answered that they have heard the word &quot;biosafety&quot;, only 39% stated to know what the word means. We asked that people about the meaning of the word and, after viewing the answers, we concluded that only a few people know completely the meaning of biosafety. 78% of the people supported the use of genetically engineered organisms and the percentage was the same when we asked if they will use products of diary consumption even when knowing that the products were or were made with GMOs.<br />
+
-
      <br />
+
-
      However, the two last questions were specific cases that showed us more clearly the factors influencing perception of people regarding genetic modification of organisms and its use to solve them. In the first case, we took as an example the AH1N1 influenza virus outbreak and the recombinant vaccine made. When asking if they considered the making of that vaccine was safe to both investigators and patients, 89% of people agreed. In the other hand, when proposing a GMO that could support the Mexican sugar industry, but that the organism will be involved in the process of making high fructose syrup from sugar, the percentage decreased to 76%, despite &quot;experts&quot; assuring that there is not any risk of using them. From these questions we conclude that health has a high priority, so people would accept the use of GMOs in the making of a vaccine that could benefit to a great ammount of people. But when the GMOs are used to help economically unsustainable industries the response is less afirmative. This could be because the GMO would be employed to make a food product of high consumption, so it seems less reliable to use.<br />
+
-
      <br />
+
-
      Up to this point, any process made in this work, considering the theoretical investigation and the information gave to us by the biosafety experts from the Centro de Biotecnologia FEMSA, have allowed us to count with the appropriate means to keep ours and the environment's safety, and also to diminish the contamination present during the project development. All the knowledge gain is of great importance to the professional development of the team in regards of biosafety and, to the same extent, biosecurity.</p>
+
-
</div> 
+
-
 
+
-
 
+
-
 
+
-
  <!--uncomment this part in sub pages so you may edit properly-->
+
-
  <!--
+
-
  <h1>Instructions</h1>
+
-
<p>Be aware that the CSS for these layouts is heavily commented. If you do most of your work in Design view, have a peek at the code to get tips on working with the CSS for the liquid layouts. You can remove these comments before you launch your site. To learn more about the techniques used in these CSS Layouts, read this article at Adobe's Developer Center - <a href="http://www.adobe.com/go/adc_css_layouts">http://www.adobe.com/go/adc_css_layouts</a>.</p>
+
-
    <h2>Clearing</h2>
+
-
    <p>Because all the columns are floated, this layout uses overflow:hidden on the .container. This clearing technique forces the .container to understand where the columns end in order to show any borders or background colors you place on the .container. If you have a large element that protrudes outside the .container, it will appear to be cut off. You also won't be able to use negative margins or absolute positioning with negative values to pull elements outside the .container or they will also won't display outside the .container.</p>
+
-
    <p>If you need to use these properties, you'll need to use a different clearing method. The most reliable will be to add a &lt;br class=&quot;clearfloat&quot; /&gt; or &lt;div  class=&quot;clearfloat&quot;&gt;&lt;/div&gt; after your final floated column (but before the .container closes). This will have the same clearing effect.</p>
+
-
    <h3>Footer</h3>
+
-
    <p>Adding a footer following the columns, yet still inside the .container, will cause this overflow:hidden clearing method to fail. You can place a .footer into a second .container outside the first one with no detrimental effects. The simplest choice may be to start with a layout containing headers and footers and remove the header to utilize the clearing methods in that layout type.</p>
+
-
    <h4>Internet Explorer Conditional Comments</h4>
+
-
    <p>These liquid layouts contain an Internet Explorer Conditional Comment (IECC) to correct two issues. </p>
+
-
    <ol>
+
-
      <li>Browsers are inconsistent in the way they round div sizes in percent-based layouts. If the browser must render a number like 144.5px or 564.5px, they have to round it to the nearest whole number. Safari and Opera round down, Internet Explorer rounds up and Firefox rounds one column up and one down filling the container completely. These rounding issues can cause inconsistencies in some layouts. In this IECC there is a 1px negative margin to fix IE. You may move it to any of the columns (and on either the left or right) to suit your layout needs.</li>
+
-
      <li>The zoom property was added to the anchor within the navigation list since, in some cases, extra white space will be rendered in IE6 and IE7. Zoom gives IE its proprietary hasLayout property to fix this issue.</li>
+
-
    </ol>
+
-
    <h4>Backgrounds</h4>
+
-
    <p>By nature, the background color on any div will only show for the length of the content. This means if you're using a background color or border to create the look of a side column, it won't extend all the way to the footer but will stop when the content ends. If the .content div will always contain more content, you can place a border on the .content div to divide it from the column.end .content </p>-->
+
-
</div>
+
-
  <!-- end .container --></div>
+
 +
<body>
 +
<div align="justify">
 +
<div style="-moz-border-radius: 4px;-webkit-border-radius: 4px;">
 +
<div class="frame" id="frame1" style="background-color:#e5e5e5;">
 +
<br>
 +
<a href=""><img src="https://static.igem.org/mediawiki/2011/7/78/Qainfo.png" width="300" height="50"> </a>
-
</div></div></body></html>
+
 
 +
 
 +
    <p class="textojustif">
 +
<br>
 +
1. Would the materials used in your project and/or your final
 +
product
 +
pose:
 +
<br><br>
 +
a. Risks to the safety and health of team members or others in the
 +
<br><br>
 +
The biological device in which we worked on this project doesn’t pose
 +
a risk to any of the team members’ health if correctly handled, however we
 +
should always consider that they carry an antibiotic resistance.
 +
Nevertheless, we must also take in mind the chemicals employed
 +
in the methods used for the completion of this project. In order to dispose
 +
any of those hazardous substances, besides following the General Safety
 +
Regulations of the Laboratory, we also followed the Safety Regulations of
 +
Centro de Biotecnología FEMSA. For example, in agarose gel electrophoresis
 +
ethidium bromide and SYBR green are commonly used; in this case, we
 +
followed a protocol for handling and disposal of the chemicals, placing objects
 +
contaminated with it in special containers. In the case of pipette tips, those
 +
were treated with benzal and sterilized by autoclave. These measures were
 +
done to avoid direct contact between team members and hazardous material.
 +
<br><br>
 +
b. Risks to the safety and health of the general public if released
 +
by design or accident?
 +
<br><br>
 +
Concerning the risks to people in general, the most dangerous
 +
problem we observed is the exposure to microorganisms that are resistant to
 +
antibiotics, posing a threat on the treatment of many diseases. For this
 +
reason, we concealed our bacteria for lab use only following the appropriate
 +
measures for handling and disposing them, such as sterilizing the tubes and
 +
dishes containing modified bacteria after using them. Regarding chemical
 +
substances, we assured that every chemical used was properly disposed,
 +
even gloves used by the team when they made contact with any hazardous
 +
substance, to make sure no people alien to the lab could be exposed to the
 +
chemicals.
 +
<br><br>
 +
c. Risks to environmental quality if released by design or
 +
accident?
 +
<br><br>
 +
Our biological devices pose few risks to the environment since
 +
we are using enzymes already present in other bacteria and non-dangerous
 +
substrates and products. However, there is a slight environmental concern
 +
in one of our constructs. This construct employs cellulose as a substrate,
 +
and since all plants have cellulose in their cell wall it is possible that they
 +
could be degraded under unusual circumstances, thus generating a negative
 +
environmental impact. Again, caution measures must be taken in order to
 +
have the modified bacteria concealed so they don’t pose a direct threat to the
 +
environment.
 +
<br><br>
 +
d. Risks to security through malicious misuse by individuals,
 +
groups
 +
or states?
 +
<br><br>
 +
Our project doesn’t have any point of risk in regards of biosecurity. Due
 +
to the nature of the process and the microorganisms involved, the devices do
 +
not cause any hazard that could be misused by individuals, groups or states
 +
to affect people’s security and wellbeing.
 +
<br><br>
 +
Please explain your responses (whether yes or no) to these
 +
questions.
 +
 
 +
Specifically, are any parts or devices in your project associated
 +
 
 +
(or known to cause):
 +
<br><br>
 +
- pathogenicity, infectivity, or toxicity?
 +
Neither of our devices has an associated risk in these fields. The only
 +
possible concern could be the EstA protein used in the device, because it is
 +
capable of the production of a toxin when the entire sequence is used; but since
 +
only a partial sequence of this protein is needed in the device (only the
 +
membrane expressing part), the toxin cannot be synthesized and the risk is
 +
therefore eliminated.
 +
<br><br>
 +
- threats to environmental quality?
 +
There is a very little, if none at all, concern about threats on the
 +
environment by our devices. As previously explained, if modified bacteria with
 +
the cellulase gene are misused or escape, there is a possibility that plants will
 +
have contact with them, creating a possible environmental damage especially
 +
if the affected organisms are ecologically valuable. However, this scenario
 +
is more a concern than a menace, as bacteria need to grow under
 +
specific conditions, and plants themselves have defense mechanisms against
 +
pathogenic microorganisms, so that possibility is greatly diminished.
 +
<br><br>
 +
- security concerns?
 +
<br><br>
 +
No, our project does not posess any danger to security in general,
 +
because the enzymes are designed only to convert sucrose into glucose and
 +
fructose, and cellulose on glucose. Regarding the rest of the devices, the
 +
parts only complement the enzymes to allow them to express and function
 +
properly, so they don’t pose a security threat.
 +
<br><br>
 +
2. If your response to any of the questions above is yes:
 +
<br><br>
 +
a. Explain how you addressed these issues in project design and while conducting laboratory work.
 +
<br><br>
 +
When designing our project, thanks to the opinion of many professors,
 +
we considered the risks that our device could have because of the enzymes
 +
and the reaction catalyzed. Interestingly enough, the enzymes are already
 +
used in other industries such as food and cleaning industries, so the
 +
measures taken to confine the bacteria were effective in case there was a risk
 +
to the environment or health in general. To accomplish an acceptable safety
 +
level, during the work time at the laboratory, every time bacteria with the
 +
constructs were handled, said work was done inside a laminar flow hood, disinfected before and after being
 +
used. Disposed materials were placed in red bags for biological hazardous
 +
waste, and then sterilized in autoclave. In the end, the material was stored in red
 +
containers so they could be disposed by a certified company.
 +
<br><br>
 +
3. Under what biosafety provisions will / do you operate?
 +
<br><br>
 +
a. Does your institution have its own biosafety rules and if so
 +
what are they?
 +
<br><br>
 +
Up to this date, there is not a general biosafety handbook for the
 +
university’s laboratories. Nevertheless, we used the handbook provided to us
 +
by the university’s research center, that consists in a handbook for handling
 +
and disposal of hazardous biological waste and a handbook with the
 +
safety rules that must be followed within the lab <a href="https://static.igem.org/mediawiki/2011/d/dd/Laboratory.Rules.pdf">(link)</a>
 +
. Thanks to this, we
 +
were able to take the appropriate safety measures in the academic lab where
 +
we worked along the summer for this project.
 +
<br><br>
 +
b. Does your institution have an Institutional Biosafety Committee
 +
equivalent group? If yes, have you discussed your project with
 +
them?<br>
 +
Describe any concerns or changes that were made based on this
 +
review.
 +
<br><br>
 +
Yes, the university’s research center, “Centro de Biotecnologia
 +
FEMSA”, has a Biosecurity Committee, composed of three doctors from the
 +
institution. All of them received information about our project, the laboratory
 +
protocols that we were using, and the biosafety measures we had; this was
 +
done to have our project checked by them so it could be improved.
 +
The Commitee told us that everything was in order and that we were
 +
following appropriately the measures taken in the university. However, one
 +
of them noted a point that we had overlooked: that the use of cellulase
 +
in a construct could affect the environment because cellulose is the main
 +
component of plants, representing thus a little biosafety concern. For this
 +
reason, the Commitee suggested us to follow the already established
 +
biosafety regulations, to not accidentally free transformed bacteria into the
 +
environment.
 +
<br><br>
 +
c. Will / did you receive any biosafety and/or lab training before
 +
beginning your project? If so, describe this training.
 +
<br><br>
 +
Before initiating the project, some of our team members had already
 +
been to a conference about the laboratory rules that must be followed in the
 +
university’s Research Center, “Centro de Biotecnologia FEMSA”. The rest of
 +
us went to this conference when the project started. In this conference, the
 +
Research Center coordinators provided us with the rules that we had to follow in
 +
those laboratories. The rulebook was adapted to the academic laboratory
 +
where we worked, the Genetic Manipulation and Molecular Diagnosis
 +
Laboratory <a href="https://static.igem.org/mediawiki/2011/d/dd/Laboratory.Rules.pdf">(link)</a>.
 +
Also, Marco Mata, head of the Research Center Safety
 +
Commission, supported us in the biosafety aspect of the project, informing us
 +
about the biosafety measures followed in the Research Center, and allowing
 +
us to take the same measures to our lab to work along the summer.
 +
<br><br>
 +
d. Does your country have national biosafety regulations or
 +
guidelines?
 +
<br><br>
 +
In Mexico, in matters of biosafety, there is a Regulation for the handling
 +
of Hazardous Biological Waste, which we followed to properly dispose all
 +
the waste generated by the project. <a href="http://www.salud.gob.mx/unidades/cdi/nom/087ecolssa.html">(link)</a>.
 +
Moreover, there is a Biosafety Law for
 +
Genetically Modified Organisms <a href="http://www.salud.gob.mx/unidades/cdi/nom/compi/ley180305.html">(link)</a>.
 +
</p>
 +
 
 +
 
 +
</div>
 +
<hr>
 +
<br/>
 +
<input type="button" value="  Up  " onmouseover="scrollUp()" onmouseout="clearTimeout(t1)">
 +
<input type="button" value=" Down " onmouseover="scrollDown()" onmouseout="clearTimeout(t1)">
 +
</div></body></html>

Latest revision as of 20:53, 20 October 2011

wiki

iGEM

 

 



1. Would the materials used in your project and/or your final product pose:

a. Risks to the safety and health of team members or others in the

The biological device in which we worked on this project doesn’t pose a risk to any of the team members’ health if correctly handled, however we should always consider that they carry an antibiotic resistance. Nevertheless, we must also take in mind the chemicals employed in the methods used for the completion of this project. In order to dispose any of those hazardous substances, besides following the General Safety Regulations of the Laboratory, we also followed the Safety Regulations of Centro de Biotecnología FEMSA. For example, in agarose gel electrophoresis ethidium bromide and SYBR green are commonly used; in this case, we followed a protocol for handling and disposal of the chemicals, placing objects contaminated with it in special containers. In the case of pipette tips, those were treated with benzal and sterilized by autoclave. These measures were done to avoid direct contact between team members and hazardous material.

b. Risks to the safety and health of the general public if released by design or accident?

Concerning the risks to people in general, the most dangerous problem we observed is the exposure to microorganisms that are resistant to antibiotics, posing a threat on the treatment of many diseases. For this reason, we concealed our bacteria for lab use only following the appropriate measures for handling and disposing them, such as sterilizing the tubes and dishes containing modified bacteria after using them. Regarding chemical substances, we assured that every chemical used was properly disposed, even gloves used by the team when they made contact with any hazardous substance, to make sure no people alien to the lab could be exposed to the chemicals.

c. Risks to environmental quality if released by design or accident?

Our biological devices pose few risks to the environment since we are using enzymes already present in other bacteria and non-dangerous substrates and products. However, there is a slight environmental concern in one of our constructs. This construct employs cellulose as a substrate, and since all plants have cellulose in their cell wall it is possible that they could be degraded under unusual circumstances, thus generating a negative environmental impact. Again, caution measures must be taken in order to have the modified bacteria concealed so they don’t pose a direct threat to the environment.

d. Risks to security through malicious misuse by individuals, groups or states?

Our project doesn’t have any point of risk in regards of biosecurity. Due to the nature of the process and the microorganisms involved, the devices do not cause any hazard that could be misused by individuals, groups or states to affect people’s security and wellbeing.

Please explain your responses (whether yes or no) to these questions. Specifically, are any parts or devices in your project associated (or known to cause):

- pathogenicity, infectivity, or toxicity? Neither of our devices has an associated risk in these fields. The only possible concern could be the EstA protein used in the device, because it is capable of the production of a toxin when the entire sequence is used; but since only a partial sequence of this protein is needed in the device (only the membrane expressing part), the toxin cannot be synthesized and the risk is therefore eliminated.

- threats to environmental quality? There is a very little, if none at all, concern about threats on the environment by our devices. As previously explained, if modified bacteria with the cellulase gene are misused or escape, there is a possibility that plants will have contact with them, creating a possible environmental damage especially if the affected organisms are ecologically valuable. However, this scenario is more a concern than a menace, as bacteria need to grow under specific conditions, and plants themselves have defense mechanisms against pathogenic microorganisms, so that possibility is greatly diminished.

- security concerns?

No, our project does not posess any danger to security in general, because the enzymes are designed only to convert sucrose into glucose and fructose, and cellulose on glucose. Regarding the rest of the devices, the parts only complement the enzymes to allow them to express and function properly, so they don’t pose a security threat.

2. If your response to any of the questions above is yes:

a. Explain how you addressed these issues in project design and while conducting laboratory work.

When designing our project, thanks to the opinion of many professors, we considered the risks that our device could have because of the enzymes and the reaction catalyzed. Interestingly enough, the enzymes are already used in other industries such as food and cleaning industries, so the measures taken to confine the bacteria were effective in case there was a risk to the environment or health in general. To accomplish an acceptable safety level, during the work time at the laboratory, every time bacteria with the constructs were handled, said work was done inside a laminar flow hood, disinfected before and after being used. Disposed materials were placed in red bags for biological hazardous waste, and then sterilized in autoclave. In the end, the material was stored in red containers so they could be disposed by a certified company.

3. Under what biosafety provisions will / do you operate?

a. Does your institution have its own biosafety rules and if so what are they?

Up to this date, there is not a general biosafety handbook for the university’s laboratories. Nevertheless, we used the handbook provided to us by the university’s research center, that consists in a handbook for handling and disposal of hazardous biological waste and a handbook with the safety rules that must be followed within the lab (link) . Thanks to this, we were able to take the appropriate safety measures in the academic lab where we worked along the summer for this project.

b. Does your institution have an Institutional Biosafety Committee equivalent group? If yes, have you discussed your project with them?
Describe any concerns or changes that were made based on this review.

Yes, the university’s research center, “Centro de Biotecnologia FEMSA”, has a Biosecurity Committee, composed of three doctors from the institution. All of them received information about our project, the laboratory protocols that we were using, and the biosafety measures we had; this was done to have our project checked by them so it could be improved. The Commitee told us that everything was in order and that we were following appropriately the measures taken in the university. However, one of them noted a point that we had overlooked: that the use of cellulase in a construct could affect the environment because cellulose is the main component of plants, representing thus a little biosafety concern. For this reason, the Commitee suggested us to follow the already established biosafety regulations, to not accidentally free transformed bacteria into the environment.

c. Will / did you receive any biosafety and/or lab training before beginning your project? If so, describe this training.

Before initiating the project, some of our team members had already been to a conference about the laboratory rules that must be followed in the university’s Research Center, “Centro de Biotecnologia FEMSA”. The rest of us went to this conference when the project started. In this conference, the Research Center coordinators provided us with the rules that we had to follow in those laboratories. The rulebook was adapted to the academic laboratory where we worked, the Genetic Manipulation and Molecular Diagnosis Laboratory (link). Also, Marco Mata, head of the Research Center Safety Commission, supported us in the biosafety aspect of the project, informing us about the biosafety measures followed in the Research Center, and allowing us to take the same measures to our lab to work along the summer.

d. Does your country have national biosafety regulations or guidelines?

In Mexico, in matters of biosafety, there is a Regulation for the handling of Hazardous Biological Waste, which we followed to properly dispose all the waste generated by the project. (link). Moreover, there is a Biosafety Law for Genetically Modified Organisms (link).